Sterling Drug Inc said submitted new drug application Food Drug Administration permission market oral form Corotrope ( milrinone ) , drug treating chronic congestive heart failure .
Sterling said application includes series study 952 patient result three multicenter study involving another 571 patient , demonstrate efficacy safety drug alternative digitalis .
Reuter & # 3 ; 